Metonitazene
From Wikipedia, the free encyclopedia
- BR: Class F1 (Prohibited narcotics)
- DE: Anlage II (Authorized trade only, not prescriptible)
- UK: Class A
- US: Schedule I
- Illegal in Sweden[1]
| Legal status | |
|---|---|
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C21H26N4O3 |
| Molar mass | 382.464 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Metonitazene is an analgesic compound related to etonitazene,[2][3] which was first reported in 1957,[4] and has been shown to have approximately 100 times the potency of morphine by central routes of administration,[5][6] but if used orally it has been shown to have approximately 10 times the potency of morphine.[7]
Its effects are similar to other opioids such as fentanyl and heroin, including analgesia, euphoria, and sleepiness.[7][8] Adverse effects include vomiting, and respiratory depression that can potentially be fatal.[9] Because of high dependency potential and dangerous adverse effects it has never been introduced into pharmacotherapy. It is instead commonly used in the illicit manufacture of counterfeit oxycodone opioid pills.[10]